Cargando…
Update on Sclerosing Cholangitis in Critically III Patients
BACKGROUND: ‛Sclerosing cholangitis in critically ill patients' (SC-CIP) is a cholestatic liver disease of unknown etiology and represents the most prevalent form of secondary sclerosing cholangitis. METHODS: This overview is based on a systematic review of the literature searching for ‘seconda...
Autores principales: | Kirchner, Gabriele I., Rümmele, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569200/ https://www.ncbi.nlm.nih.gov/pubmed/26468312 http://dx.doi.org/10.1159/000431031 |
Ejemplares similares
-
An update on treatment options for primary sclerosing cholangitis
por: Iravani, Shahrokh, et al.
Publicado: (2020) -
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019) -
Secondary sclerosing cholangitis in critically ill patients: current perspectives
por: Gudnason, Hafsteinn O, et al.
Publicado: (2017) -
Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006) -
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients
por: Jüngst, Christoph, et al.
Publicado: (2017)